Skip to main content

Advertisement

SpringerLink
Log in

Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

An Erratum to this article was published on 20 May 2017

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Marzocchi G, Castagnetti F, Luatti S, Baldazzi C, Stacchini M, Gugliotta G et al (2011) Variant Philadelphia translocations: molecular-cytogenetic characterization and prognostic influence on frontline imatinib therapy, a GIMEMA Working Party on CML analysis. Blood 117(25):6793–6800

    Article  CAS  PubMed  Google Scholar 

  2. Gorusu M, Benn P, Li Z, Fang M (2007) On the genesis and prognosis of variant translocations in chronic myeloid leukemia. Cancer Genet Cytogenet 173(2):97–106

    Article  CAS  PubMed  Google Scholar 

  3. Johansson B, Fioretos T, Mitelman F (2002) Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol 107(2):76–94

    Article  CAS  PubMed  Google Scholar 

  4. Luatti S, Castagnetti F, Marzocchi G, Baldazzi C, Gugliotta G, Iacobucci I et al (2012) Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis. Blood 120(4):761–767

    Article  CAS  PubMed  Google Scholar 

  5. Chen Z, Cortes JE, Jorgensen JL, Wang W, Yin CC, You MJ et al (2016) Differential impact of additional chromosomal abnormalities in myeloid vs lymphoid blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia 30(7):1606-1609

  6. Chen Z, Shao C, Wang W, Zuo Z, Mou X, Hu SJ et al. (2016) Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Leukemia

  7. Wang W, Cortes JE, Tang G, Khoury JD, Wang S, Bueso-Ramos CE et al. (2016) Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood

  8. Wang W, Cortes JE, Lin P, Beaty MW, Ai D, Amin HM et al (2015) Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors. Blood 126(14):1699–1706

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Wang W, Cortes JE, Lin P, Khoury JD, Ai D, Tang Z et al (2015) Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leukemia 29(11):2263–2266

    Article  CAS  PubMed  Google Scholar 

  10. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A et al (2000) Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 95(3):738–743

    CAS  PubMed  Google Scholar 

  11. Potter AM, Watmore AE, Cooke P, Lilleyman JS, Sokol RJ (1981) Significance of non-standard Philadelphia chromosomes in chronic granulocytic leukaemia. Br J Cancer 44(1):51–54

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Richebourg S, Eclache V, Perot C, Portnoi MF, Van den Akker J, Terre C et al (2008) Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy. Cancer Genet Cytogenet 182(2):95–102

    Article  CAS  PubMed  Google Scholar 

  13. El-Zimaity MM, Kantarjian H, Talpaz M, O’Brien S, Giles F, Garcia-Manero G et al (2004) Results of imatinib mesylate therapy in chronic myelogenous leukaemia with variant Philadelphia chromosome. Br J Haematol 125(2):187–195

    Article  CAS  PubMed  Google Scholar 

  14. Fabarius A, Leitner A, Hochhaus A, Muller MC, Hanfstein B, Haferlach C et al (2011) Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood 118(26):6760–6768

    Article  CAS  PubMed  Google Scholar 

  15. Haigh S, Cuthbert G (2004) Fluorescence in situ hybridization characterization of different cryptic BCR-ABL rearrangements in chronic myeloid leukemia. Cancer Genet Cytogenet 155(2):132–137

    Article  CAS  PubMed  Google Scholar 

  16. Morel F, Herry A, Le Bris MJ, Morice P, Bouquard P, Abgrall JF et al (2003) Contribution of fluorescence in situ hybridization analyses to the characterization of masked and complex Philadelphia chromosome translocations in chronic myelocytic leukemia. Cancer Genet Cytogenet 147(2):115–120

    Article  CAS  PubMed  Google Scholar 

Download references

Authors’ contribution

ZG and SH designed the study, collected and analyzed data, and wrote the manuscript. All authors read and approved the final manuscript.

Author information

Authors and Affiliations

  1. Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA

    Zimu Gong, Lan Zheng, Zhenya Tang, Zi Chen, Wei Wang, Shi Bai, Guilin Tang, L. Jeffrey Medeiros & Shimin Hu

  2. Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China

    Zimu Gong

Authors
  1. Zimu Gong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lan Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhenya Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zi Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shi Bai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Guilin Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. Jeffrey Medeiros
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Shimin Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shimin Hu.

Ethics declarations

The study is approved by the Institutional Review Board at the University of Texas MD Anderson Cancer Center.

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s00277-017-3025-7.

Electronic supplementary material

ESM 1

(XLSX 21 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gong, Z., Zheng, L., Tang, Z. et al. Role of complexity of variant Philadelphia chromosome in chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy. Ann Hematol 96, 501–504 (2017). https://doi.org/10.1007/s00277-016-2892-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2892-7

Keywords

Search

Navigation